Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1985-02-25
1985-12-17
Milestone, Norma S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
2603307, C07D26720, A61K 3155
Patent
active
045593370
ABSTRACT:
This invention relates to 8-chlorodibenz[b,f][1,4]-oxazepine-10(11H)-carboxylic acid, 2-(alkoxy-containing acyl)hydrazides that are useful as prostaglandin antagonists and analgesic agents.
REFERENCES:
patent: 3534019 (1970-10-01), Coyne
patent: 3917649 (1975-11-01), Mueller
patent: 3989719 (1976-11-01), Mueller
patent: 3992375 (1976-11-01), Mueller
patent: 4045442 (1977-08-01), Mueller
patent: 4125532 (1978-11-01), Mueller
patent: 4170593 (1979-10-01), Mueller
J. H. Sanner, "Antagonism of Prostaglandin E.sub.2 by 1-Acetyl-2-(8-Chloro-10,11-Dihydrodibenz[b,f][1,4]Oxazepine-10-Carbonyl)Hy drazine (SC-19220)," Arch. Int. Pharmacodyn., 180, 46, (1969).
G.D. Searle & Co.
McDonnell John J.
Milestone Norma S.
LandOfFree
8-Chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-(al does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-Chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-(al, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-Chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-(al will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2175136